Shares of Medical Properties Trust, Inc. (NYSE:MPW - Get Free Report) have received an average recommendation of "Reduce" from the eleven brokerages that are presently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $5.22.
Several research firms have weighed in on MPW. Wolfe Research upgraded shares of Medical Properties Trust to a "hold" rating in a research report on Monday. Truist Financial increased their price objective on Medical Properties Trust from $5.00 to $6.00 and gave the company a "hold" rating in a research report on Friday, September 13th. Colliers Securities upgraded Medical Properties Trust from a "neutral" rating to a "buy" rating and set a $6.50 target price for the company in a research report on Friday, September 13th. Finally, BNP Paribas cut shares of Medical Properties Trust from an "outperform" rating to a "neutral" rating and reduced their price target for the company from $6.00 to $4.00 in a research report on Tuesday, July 2nd.
Get Our Latest Research Report on MPW
In other news, Director Elizabeth N. Pitman sold 10,025 shares of the business's stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $4.98, for a total value of $49,924.50. Following the completion of the transaction, the director now owns 68,653 shares in the company, valued at $341,891.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Elizabeth N. Pitman bought 8,087 shares of the business's stock in a transaction on Wednesday, September 18th. The stock was acquired at an average price of $6.01 per share, with a total value of $48,602.87. Following the transaction, the director now owns 76,740 shares in the company, valued at approximately $461,207.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Elizabeth N. Pitman sold 10,025 shares of the stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $4.98, for a total value of $49,924.50. Following the transaction, the director now directly owns 68,653 shares in the company, valued at $341,891.94. The disclosure for this sale can be found here. Corporate insiders own 1.53% of the company's stock.
Institutional investors have recently added to or reduced their stakes in the business. Wolverine Asset Management LLC increased its stake in shares of Medical Properties Trust by 0.6% in the second quarter. Wolverine Asset Management LLC now owns 405,145 shares of the real estate investment trust's stock worth $1,746,000 after purchasing an additional 2,246 shares in the last quarter. Keynote Financial Services LLC increased its stake in Medical Properties Trust by 4.8% in the 2nd quarter. Keynote Financial Services LLC now owns 59,188 shares of the real estate investment trust's stock worth $255,000 after buying an additional 2,715 shares in the last quarter. Arizona State Retirement System raised its holdings in Medical Properties Trust by 1.9% during the second quarter. Arizona State Retirement System now owns 167,722 shares of the real estate investment trust's stock valued at $723,000 after acquiring an additional 3,103 shares during the period. Collective Family Office LLC lifted its position in shares of Medical Properties Trust by 16.8% in the first quarter. Collective Family Office LLC now owns 21,720 shares of the real estate investment trust's stock valued at $102,000 after acquiring an additional 3,120 shares in the last quarter. Finally, Panagora Asset Management Inc. boosted its stake in shares of Medical Properties Trust by 23.6% in the second quarter. Panagora Asset Management Inc. now owns 19,591 shares of the real estate investment trust's stock worth $84,000 after acquiring an additional 3,735 shares during the period. 71.79% of the stock is currently owned by institutional investors.
Shares of MPW stock opened at $5.89 on Friday. The firm's 50-day simple moving average is $5.02 and its two-hundred day simple moving average is $4.79. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.93 and a current ratio of 2.93. Medical Properties Trust has a 52 week low of $2.92 and a 52 week high of $6.55. The firm has a market cap of $3.53 billion, a price-to-earnings ratio of -2.65, a P/E/G ratio of 0.84 and a beta of 1.28.
Medical Properties Trust (NYSE:MPW - Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The real estate investment trust reported ($0.54) earnings per share for the quarter, missing analysts' consensus estimates of $0.21 by ($0.75). The company had revenue of $266.60 million for the quarter, compared to analyst estimates of $259.53 million. During the same period last year, the company earned $0.48 EPS. The company's quarterly revenue was down 21.0% compared to the same quarter last year. As a group, equities analysts forecast that Medical Properties Trust will post 0.87 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 10th. Investors of record on Monday, September 9th will be paid a $0.08 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $0.32 annualized dividend and a dividend yield of 5.43%. Medical Properties Trust's payout ratio is -14.41%.
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.